馬瑜婷，研究員，博士生導(dǎo)師，系統(tǒng)院執(zhí)行副院長。曾獲江蘇省自然科學(xué)一等獎(jiǎng)、中國青年女科學(xué)家獎(jiǎng)、鐘南山青年科技創(chuàng)新獎(jiǎng)、中國青年五四獎(jiǎng)?wù)?、全國先進(jìn)工作者、國務(wù)院政府特殊津貼等；入選中共二十大代表；入選國家萬人計(jì)劃領(lǐng)軍人才、國家海外高層次人才等；獲科技創(chuàng)新2030重大、國自然青B等項(xiàng)目資助。
     院校2015年引進(jìn)人才，曾在法國國家健康與醫(yī)學(xué)研究院、古斯塔夫魯西研究所、巴黎第五大學(xué)科德利埃研究中心完成博士后工作。

長期開展應(yīng)激重塑免疫景觀的研究，提出“多重應(yīng)激的免疫識別和調(diào)控”新理論，助力免疫治療新靶點(diǎn)和老藥新用策略的挖掘開發(fā)，承擔(dān)國家和省部級科研課題19項(xiàng)，在Nat Med、Nat Rev Immunol、Science等期刊發(fā)表論文60余篇，H指數(shù)40，入選全球前2%頂尖科學(xué)家，參編中英文專著5部，培養(yǎng)碩博士研究生20余名，擔(dān)任中國免疫學(xué)會理事、中國生物醫(yī)學(xué)工程學(xué)會常務(wù)理事等，是多個(gè)學(xué)術(shù)期刊資深副主編或編委。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

1.Qin S#, Yang Y#, Wang H#, Li M#, Deng Y, Chen Y, Li C, Peng L, Xu L, Qiu X, Guan Y, Wang S, He Y, Wang X*, Ma Y*, Huang L*, Chen D*. scBrainScope: cross-species multidimensional brain atlas. Nucleic Acids Res. 2025 Nov 17:gkaf1092. (IF= 13.1)

2.Li P#, Liang M#, Zhu J#, Chen J#, Xia L, Jin Z, Zhang X, Zhang S, Wang Q, Liu Z, Ping Y, Wang Z, Wong CC, Zhang Y, Yang H, Ye Z, Ma Y*. Elevated activity of plasma dipeptidyl peptidase 4 upon stress can be targeted to reverse tumor immunosuppression. Pharmacol Res. 2025, 215:107696. (IF=10.5)

3.Ma Y#*, Kroemer G. The cancer-immune dialogue in the context of stress. Nat Rev Immunol. 2024, 24(4):264-281. (IF= 67.7)

4.Chen J#, Jin Z, Zhang S, Zhang X, Li P, Yang H, Ma Y*. Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis. Cell Mol Immunol 2023, 20(1):51-64. (IF= 21.8)

5.Ma Y#*. Tpt1 the balance toward immunosuppression upon cell death. Nat Immunol. 2021, 22(8):940-942. (IF= 27.8)

6.Yang H#, Xia L#, Chen J#, Zhang S, Martin V, Li Q, Lin S, Chen J, Calmette J, Lu M, Fu L, Yang J, Pan Z, Yu K, He J, Morand E, Schlecht-Louf G, Krzysiek R, Zitvogel L, Kang B, Zhang Z, Leader A, Zhou P, Lanfumey L, Shi M, Kroemer G*, Ma Y*. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nat Med. 2019, 25(9):1428-1441. (IF= 58.7, C100, F1000)

7.Yang H, Yamazaki T, Pietrocola F, Zhou H, Zitvogel L, Ma Y*, Kroemer G*. STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells. Cancer Res.2015, 15;75(18):3812-22. (IF= 9.088)

8.Vacchelli E#, Ma Y#, Baracco EE, Sistigu A, Enot DP, Pietrocola F, Yang H, Adjemian S, Chaba K, Semeraro M, Signore M, De Ninno A, Lucarini V, Peschiaroli F, Businaro L, Gerardino A, Manic G, Ulas T, Günther P, Schultze JL, Kepp O, Stoll G, Lefebvre C, Mulot C, Castoldi F, Rusakiewicz S, Ladoire S, Apetoh L, Bravo-San Pedro JM, Lucattelli M, Delarasse C, Boige V, Ducreux M, Delaloge S, Borg C, André F, Schiavoni G, Vitale I, Laurent-Puig P, Mattei F, Zitvogel L*, Kroemer G*. Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Science. 2015, 20;350(6263):972-8. (IF= 44.7, C100, F1000)

9.Ma Y#, Adjemian S#, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, Portela Catani JP, Hannani D, Duret H, Steegh K, Martins I, Schlemmer F, Michaud M, Kepp O, Sukkurwala AQ, Menger L, Vacchelli E, Droin N, Galluzzi L, Krzysiek R, Gordon S, Taylor PR, Van Endert P, Solary E, Smyth MJ, Zitvogel L*, Kroemer G*. Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity. 2013, 18;38(4):729-41. (IF=21.884, ESI, C100)

10.Ma Y#, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N, Lasarte JJ, Matsuzaki G, Ikuta K, Ryffel B, Benlagha K, Tesnière A, Ibrahim N, Déchanet-Merville J, Chaput N, Smyth MJ, Kroemer G*, Zitvogel L*. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med. 2011, 208(3):491-503. (IF= 10.6, C100)